4-75597184-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001330724.2(CDKL2):āc.1073G>Cā(p.Gly358Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000167 in 1,612,360 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001330724.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CDKL2 | NM_001330724.2 | c.1073G>C | p.Gly358Ala | missense_variant | 9/14 | ENST00000307465.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CDKL2 | ENST00000307465.9 | c.1073G>C | p.Gly358Ala | missense_variant | 9/14 | 2 | NM_001330724.2 | P1 | |
CDKL2 | ENST00000429927.6 | c.1073G>C | p.Gly358Ala | missense_variant | 9/12 | 1 | |||
CDKL2 | ENST00000515793.1 | upstream_gene_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152018Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000438 AC: 11AN: 251170Hom.: 0 AF XY: 0.0000515 AC XY: 7AN XY: 135806
GnomAD4 exome AF: 0.00000685 AC: 10AN: 1460224Hom.: 0 Cov.: 30 AF XY: 0.00000826 AC XY: 6AN XY: 726594
GnomAD4 genome AF: 0.000112 AC: 17AN: 152136Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74372
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 18, 2023 | The c.1073G>C (p.G358A) alteration is located in exon 9 (coding exon 8) of the CDKL2 gene. This alteration results from a G to C substitution at nucleotide position 1073, causing the glycine (G) at amino acid position 358 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at